Boswellic acids synergize antitumor activity and protect against the cardiotoxicity of doxorubicin in mice bearing Ehrlich’s carcinoma

Canadian Journal of Physiology and Pharmacology

Volumn 93, Issue 8, 2015, Pages 695-708

  Ali, Shimaa A ^a   Zaitone, Sawsan A ^b   Moustafa, Yasser M ^b  

^a Suez Canal Authority Hospital   (Egypt)

^b SUEZ CANAL UNIVERSITY   (Egypt)

Author keywords

Antitumor activity; Apoptosis; Boswellic acids; Cardiotoxicity; Doxorubicin; Ehrlich s ascites carcinoma; Mice

Indexed keywords

ANTINEOPLASTIC AGENT; BOSWELLIC ACID; CATALASE; CELL NUCLEUS DNA; CREATINE KINASE MB; DOXORUBICIN; GLUTATHIONE; LACTATE DEHYDROGENASE; MALONALDEHYDE; PROTECTIVE AGENT; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID; ANTINEOPLASTIC ANTIBIOTIC; BIOLOGICAL MARKER; TRITERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY MASS; CARDIOTOXICITY; COMPARATIVE STUDY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DNA FRAGMENTATION; DRUG MEGADOSE; EHRLICH ASCITES TUMOR; ENZYME ACTIVITY; FEMALE; GEL ELECTROPHORESIS; HEART MUSCLE; HEART PROTECTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INVESTIGATIVE PROCEDURES; LACTATE DEHYDROGENASE BLOOD LEVEL; LOW DRUG DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; WESTERN BLOTTING; ANIMAL; APOPTOSIS; BLOOD; CARCINOMA, EHRLICH TUMOR; CARDIAC MUSCLE CELL; CELL PROTECTION; CHEMICALLY INDUCED; DRUG EFFECTS; DRUG POTENTIATION; HEART DISEASES; METABOLISM; PATHOLOGY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BIOMARKERS; CARCINOMA, EHRLICH TUMOR; CYTOPROTECTION; DOXORUBICIN; DRUG SYNERGISM; FEMALE; HEART DISEASES; MICE; MYOCYTES, CARDIAC; TRITERPENES;

EID: 84938602343     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2014-0524     Document Type: Article

References (77)

1. Abd-Alhaseeb, M.M., Zaitone, S.A., Abou-El-Ela, S.H., and Moustafa, Y.M. 2014. Olmesartan potentiates the anti-angiogenic effect of sorafenib in mice bearing Ehrlich’s ascites carcinoma: role of angiotensin (1-7). PLoS One, 9(1): e85891. doi:10.1371/journal.pone.0085891.PMID:24465768.
2. Abdel-aleem, S., El-Merzabani, M.M., Sayed-Ahmed, M., Taylor, D.A., and Lowe, J.E. 1997. Acute and chronic effects of adriamycin on fatty acid oxidation in isolated cardiac myocytes. J. Mol. Cell. Cardiol. 29(2): 789–797. doi:10.1006/jmcc.1996.0323.PMID:9140835.
3. Aebi, H. 1984. Catalase in vitro. Methods Enzymol. 105: 121–126. doi:10.1016/S0076-6879(84)05016-3.PMID:6727660.
4. Agrawal, S., and Saraswati, S. 2012. Antiangiogenic and cytotoxic activity of boswellic acid on breast cancer MCF-7 cells. Biomed. Prev. Nutr. 2: 31–37. doi:10.1016/j.bionut.2011.09.006.
5. Agrawal, S.S., Saraswati, S., Mathur, R., and Pandey, M. 2011. Antitumor properties of boswellic acid against Ehrlich ascites cells bearing mouse. Food Chem. Toxicol. 49(9): 1924–1934. doi:10.1016/j.fct.2011.04.007.PMID:21513768.
6. Ahmad, S.S., Idris, S.F., Follows, G.A., and Williams, M.V. 2012. Primary testicular lymphoma. Clin. Oncol. (R. Coll. Radiol.), 24(5): 358–365. doi:10.1016/j.clon.2012.02.005.
7. Aluise, C.D., Miriyala, S., Noel, T., Sultana, R., Jungsuwadee, P., Taylor, T.J., et al. 2011. 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-alpha release: implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radic. Biol. Med. 50(11): 1630–1638. doi:10.1016/j.freeradbiomed.2011.03.009.PMID:21421044.
8. Ammon, H.P. 2006. Boswellic acids in chronic inflammatory diseases. Planta Med. 72(12): 1100–1116. doi:10.1055/s-2006-947227.PMID:17024588.
9. Ammon, H.P. 2010. Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Phytomedicine, 17(11): 862–867. doi:10.1016/j.phymed.2010.03.003.PMID:20696559.
10. Antonsson, B. 2004. Mitochondria and the Bcl-2 family proteins in apoptosis signaling pathways. Mol. Cell. Biochem. 256–257(1–2): 141–155. doi:10.1023/B:MCBI.0000009865.70898.36.PMID:14977177.
11. Banno, N., Akihisa, T., Yasukawa, K., Tokuda, H., Tabata, K., Nakamura, Y., et al. 2006. Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri. J. Ethnopharmacol. 107(2): 249–253. doi:10.1016/j.jep.2006.03.006.PMID:16621377.
12. Bast, A., Haenen, G.R., Bruynzeel, A.M., and Van der Vijgh, W.J. 2007. Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials. Cardiovasc. Toxicol. 7(2): 154–159. doi:10.1007/s12012-007-0018-0.PMID: 17652822.
13. Berthiaume, J.M., and Wallace, K.B. 2007. Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol. Toxicol. 23(1): 15–25. doi:10.1007/s10565-006-0140-y. PMID:17009097.
14. Beutler, E., Duron, O., and Kelly, B.M. 1963. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 61: 882–888.PMID:13967893.
15. Boussios, S., Pentheroudakis, G., Katsanos, K., and Pavlidis, N. 2012. Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management. Ann. Gastroenterol. 25(2): 106–118.PMID:24713845.
16. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72(1–2): 248–254. doi:10.1016/0003-2697(76)90527-3.PMID: 942051.
17. Chashoo, G., Singh, S.K., Mondhe, D.M., Sharma, P.R., Andotra, S.S., Shah, B.A., et al. 2011a. Potentiation of the antitumor effect of 11-keto-beta-boswellic acid by its 3-alpha-hexanoyloxy derivative. Eur. J. Pharmacol. 668(3): 390–400. doi:10.1016/j.ejphar.2011.07.024.PMID:21821018.
18. Chashoo, G., Singh, S.K., Sharma, P.R., Mondhe, D.M., Hamid, A., Saxena, A., et al. 2011b. A propionyloxy derivative of 11-keto-beta-boswellic acid induces apoptosis in HL-60 cells mediatedthrough topoisomerase I & II inhibition. Chem. Biol. Interact. 189(1–2): 60–71. doi:10.1016/j.cbi.2010.10.017.PMID: 21056033.
19. Childs, A.C., Phaneuf, S.L., Dirks, A.J., Phillips, T., and Leeuwenburgh, C. 2002. Doxorubicin treatment in vivo causes cytochrome C release andcardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res. 62(16): 4592–4598.PMID: 12183413.
20. Chou, T.C., and Martin, N. 2005. CompuSyn for drug combinations: PC Software and User’s Guide: a computer program for quantitation of synergism and antagonism in drug combinations, and the determination of IC50 and ED50 and LD50 values. Paramus (NJ): ComboSyn.
21. Chou, T.C., and Talalay, P. 1983. Analysis of combined drug effects: a new look at a very old problem. Trends Pharmacol. Sci. 4: 450–454. doi:10.1016/0165-6147(83)90490-X.
22. Chou, T.C., and Talalay, P. 1984. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22: 27–55. doi:10.1016/0065-2571(84)90007-4.PMID:6382953.
23. Clark, C.E., Arnold, E., Lasserson, T.J., and Wu, T. 2010. Herbal interventions for chronic asthma in adults and children: a systematic review and metaanalysis. Prim. Care Respir. J. 19(4): 307–314. doi:10.4104/pcrj.2010.00041.PMID:20640388.
24. Clarke, J.O., and Mullin, G.E. 2008. A review of complementary and alternative approaches to immunomodulation. Nutr. Clin. Pract. 23(1): 49–62. doi:10.1177/011542650802300149.PMID:18203964.
25. Das, J., Ghosh, J., Manna, P., and Sil, P.C. 2011. Taurine suppresses doxorubicintriggered oxidative stress and cardiac apoptosis in rat via up-regulation of PI3-K/Aktand inhibition of p53, p38-JNK. Biochem. Pharmacol. 81(7): 891–909. doi:10.1016/j.bcp.2011.01.008. PMID:21295553.
26. Desai, V.G., Herman, E.H., Moland, C.L., Branham, W.S., Lewis, S.M., Davis, K.J., et al. 2013. Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model. Toxicol. Appl. Pharmacol. 266(1): 109–121. doi:10.1016/j.taap.2012.10.025.PMID:23142469.
27. Fajardo, G., Zhao, M., Powers, J., and Bernstein, D. 2006. Differential cardiotoxic/ cardioprotective effects of beta-adrenergic receptor subtypes in myocytes and fibroblasts in doxorubicin cardiomyopathy. J. Mol. Cell. Cardiol. 40(3): 375–383. doi:10.1016/j.yjmcc.2005.12.004.PMID:16458323.
28. Fisher, P.W., Salloum, F., Das, A., Hyder, H., and Kukreja, R.C. 2005. Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity. Circulation, 111(13): 1601–1610. doi:10.1161/01.CIR.0000160359.49478.C2.PMID:15811867.
29. Fossati, P., Prencipe, L., and Berti, G. 1980. Use of 3,5-dichloro-2- hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin. Chem. 26: 227–231.PMID:7353268.
30. Fouad, A.A., Albuali, W.H., Al-Mulhim, A.S., and Jresat, I. 2013. Cardioprotective effect of cannabidiol in rats exposed to doxorubicin toxicity. Environ. Toxicol. Pharmacol. 36(2): 347–357. doi:10.1016/j.etap.2013.04.018.PMID:23721741.
31. Gandhi, H., Patel, V.B., Mistry, N., Patni, N., Nandania, J., and Balaraman, R. 2013. Doxorubicin mediated cardiotoxicity in rats: protective role of felodipine on cardiac indices. Environ. Toxicol. Pharmacol. 36(3): 787–795. doi:10.1016/j.etap.2013.07.007.PMID:23958971.
32. Gibson, R.J., Bowen, J.M., Alvarez, E., Finnie, J., and Keefe, D.M. 2007. Establishment of a single-dose irinotecan model of gastrointestinal mucositis. Chemotherapy, 53(5): 360–369. doi:10.1159/000107458.PMID:17713326.
33. Glaser, T., Winter, S., Groscurth, P., Safayhi, H., Sailer, E.R., Ammon, H.P., et al. 1999. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity. Br. J. Cancer, 80(5–6): 756–765. doi:10.1038/sj.bjc.6690419.PMID:10360653.
34. Gupta, S. 2003. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). Int. J. Oncol. 22(1): 15–20. doi:10.3892/ijo.22.1.15.PMID:12469180.
35. Helgadottir, A., Manolescu, A., Thorleifsson, G., Gretarsdottir, S., Jonsdottir, H., Thorsteinsdottir, U., et al. 2004. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36(3): 233–239. doi:10.1038/ng1311.PMID:14770184.
36. Hoernlein, R.F., Orlikowsky, T., Zehrer, C., Niethammer, D., Sailer, E.R., Simmet, T., et al. 1999. Acetyl-11-keto-beta-boswellicacid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I. J. Pharmacol. Exp. Ther. 288(2): 613–619.PMID:9918566.
37. Janssen, G., Bode, U., Breu, H., Dohrn, B., Engelbrecht, V., and Gobel, U. 2000. Boswellic acids in the palliative therapy of childrenwith progressive or relapsed brain tumors. Klin. Padiatr. 212(4): 189–195. doi:10.1055/s-2000-9676.PMID:10994549.
38. Jing, Y., Nakajo, S., Xia, L., Nakaya, K., Fang, Q., Waxman, S., et al. 1999. Boswellic acid acetate induces differentiation and apoptosis in leukemiacell lines. Leuk. Res. 23(1): 43–50. doi:10.1016/S0145-2126(98)00096-4.PMID:9933134.
39. Kokkiripati, P.K., Bhakshu, L.M., Marri, S., Padmasree, K., Row, A.T., Raghavendra, A.S., et al. 2011. Gum resin of Boswellia serrata inhibited human monocytic (THP-1) cell activation and platelet aggregation. J. Ethnopharmacol. 137(1): 893–901. doi:10.1016/j.jep.2011.07.004.PMID:21771654.
40. Liu, J.J., Nilsson, A., Oredsson, S., Badmaev, V., and Duan, R.D. 2002. Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway. Int. J. Mol. Med. 10(4): 501–505. doi:10.3892/ijmm.10.4.501.PMID:12239601.
41. Liu, T.J., Yeh, Y.C., Ting, C.T., Lee, W.L., Wang, L.C., Lee, H.W., et al. 2008. Ginkgo biloba extract 761 reduces doxorubicin-induced apoptotic damage in rat hearts and neonatal cardiomyocytes. Cardiovasc. Res. 80(2): 227–235. doi:10.1093/cvr/cvn192. PMID:18632596.
42. Liu, X., Chua, C.C., Gao, J., Chen, Z., Landy, C.L., Hamdy, R., et al. 2004. Pifithrinalpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice. Am. J. Physiol. Heart Circ. Physiol. 286(3): H933–H939. doi:10.1152/ajpheart.00759.2003.PMID:14766674.
43. Luanpitpong, S., Chanvorachote, P., Nimmannit, U., Leonard, S.S., Stehlik, C., Wang, L., et al. 2012. Mitochondrial superoxide mediates doxorubicininduced keratinocyte apoptosis through oxidative modification of ERK and Bcl-2 ubiquitination. Biochem. Pharmacol. 83(12): 1643–1654. doi:10.1016/j.bcp.2012.03.010.PMID:22469513.
44. Mattson, M.P., and Kroemer, G. 2003. Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. Trends Mol. Med. 9(5): 196–205. doi:10.1016/S1471-4914(03)00046-7.PMID:12763524.
45. Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., and Gianni, L. 2004. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56(2): 185–229. doi:10.1124/pr.56.2.6.PMID:15169927.
46. Miyamoto, Y., Koh, Y.H., Park, Y.S., Fujiwara, N., Sakiyama, H., Misonou, Y., et al. 2003. Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses. Biol. Chem. 384(4): 567–574. doi:10.1515/BC.2003.064.PMID:12751786.
47. Moghrabi, A., Levy, D.E., Asselin, B., Barr, R., Clavell, L., Hurwitz, C., et al. 2007. Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood, 109(3): 896–904. doi: 10.1182/blood-2006-06-027714.PMID:17003366.
48. Mothana, R.A. 2011. Anti-inflammatory, antinociceptive and antioxidant activities of the endemic soqotraen Boswellia elongata Balf. f. and Jatropha unicostata Balf. f. in different experimental models. Food Chem. Toxicol. 49(10): 2594–2599.
49. Moussaieff, A., and Mechoulam, R. 2009. Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials. J. Pharm. Pharmacol. 61(10): 1281–1293. doi:10.1211/jpp.61.10.0003.PMID:19814859.
50. Nishikimi, M., Roa, N.A., and Yogi, K. 1972. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem. Biophys. Res. Commun. 46(2): 849–854. doi:10.1016/S0006-291X(72)80218-3.PMID:4400444.
51. Nohl, H., Gille, L., and Staniek, K. 1998. The exogenous NADH dehydrogenase of heart mitochondria is the key enzyme responsible for selective cardiotoxicity of anthracyclines. Z. Naturforsch. C, 53(3–4): 279–285.
52. Ohkawa, H., Ohishi, W., and Yagi, K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95: 351–358. doi:10.1016/0003-2697(79)90738-3.PMID:36810.
53. Parker, M.A., King, V., and Howard, K.P. 2001. Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayers. Biochim. Biophys. Acta, 1514(2): 206–216. doi:10.1016/S0005-2736(01)00371-6.PMID:11557021.
54. Patel, V., Upaganlawar, A., Zalawadia, R., and Balaraman, R. 2010. Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: A biochemical, electrocardiographic and histoarchitectural evaluation. Eur. J. Pharmacol. 644(1–3): 160–168. doi:10.1016/j.ejphar.2010.06.065.PMID:20624385.
55. Sabina, E.P., Indu, H., and Rasool, M. 2012. Efficacy of boswellic acid on lysosomal acid hydrolases, lipid peroxidation and anti-oxidant status in gouty arthritic mice. Asian Pac. J. Trop. Biomed. 2(2): 128–133. doi:10.1016/S2221-1691(11)60206-2.PMID:23569882.
56. Safayhi, H., Boden, S.E., Schweizer, S., and Ammon, H.P. 2000. Concentrationdependent potentiating and inhibitory effects of Boswellia extracts on 5-lipoxygenase product formation in stimulated PMNL. Planta Med. 66(2): 110–113. doi:10.1055/s-2000-11136.PMID:10763581.
57. Saraswati, S., Agrawal, S.S., and Alhaider, A.A. 2013. Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor. Chem. Biol. Interact. 206(2): 153–165. doi:10.1016/j.cbi.2013.09.004.PMID:24051192.
58. Satoh, K. 1978. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin. Chim. Acta, 90: 37–43.
59. Shah, B.A., Kumar, A., Gupta, P., Sharma, M., Sethi, V.K., Saxena, A.K., et al. 2007. Cytotoxic and apoptotic activities of novel amino analogues of boswellic acids. Bioorg. Med. Chem. Lett. 17(23): 6411–6416. doi:10.1016/j.bmcl.2007.10.011.PMID:17950603.
60. Singh, G.B., Bani, S., and Singh, S. 1996. Toxicity and safety evaluation of boswellic acids. Phytomedicine, 3(1): 87–90. doi:10.1016/S0944-7113(96)80018-3.PMID:23194869.
61. Singh, S.K., Bhusari, S., Singh, R., Saxena, A., Mondhe, D., and Qazi, G.N. 2007. Effect of acetyl 11-keto beta-boswellic acid on metastatic growth factor responsible for angiogenesis. Vascul. Pharmacol. 46(5): 333–337. doi:10.1016/j.vph.2006.09.008.PMID:17257903.
62. Singh, S., Khajuria, A., Taneja, S.C., Khajuria, R.K., Singh, J., Johri, R.K., et al. 2008. The gastric ulcerprotective effect of boswellic acids, a leukotriene inhibitor from Boswellia serrata, in rats. Phytomedicine, 15(6–7): 408–415. doi: 10.1016/j.phymed.2008.02.017.PMID:18424019.
63. Sledge, G.W., Neuberg, D., Bernardo, P., Ingle, J.N., Martino, S., Rowinsky, E.K., et al. 2003. Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193). J. Clin. Oncol. 21(4): 588–592. doi:10.1200/JCO.2003.08.013.PMID:12586793.
64. Soni, H., Pandya, G., Patel, P., Acharya, A., Jain, M., and Mehta, A.A. 2011. Beneficial effects of carbon monoxide-releasing molecule-2 (CORM-2) on acute doxorubicin cardiotoxicity in mice: role of oxidative stress and apoptosis. Toxicol. Appl. Pharmacol. 253(1): 70–80. doi:10.1016/j.taap.2011.03.013.PMID: 21443895.
65. Takahashi, M., Sung, B., Shen, Y., Hur, K., Link, A., Boland, C.R., et al. 2012. Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family. Carcinogenesis, 33(12): 2441–2449. doi:10.1093/carcin/bgs286.PMID:22983985.
66. Tamilselvan, J., Jayaraman, G., Sivarajan, K., and Panneerselvam, C. 2007. Agedependent upregulation of p53 and cytochrome c release and susceptibility to apoptosis in skeletal muscle fiber of aged rats: role of carnitine and lipoic acid. Free Radic. Biol. Med. 43(12): 1656–1669. doi:10.1016/j.freeradbiomed.2007.08.028.PMID:18037131.
67. Ueno, M., Kakinuma, Y., Yuhki, K., Murakoshi, N., Iemitsu, M., Miyauchi, T., et al. 2006. Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo. J. Pharmacol. Sci. 101(2): 151–158. doi:10.1254/jphs.FP0050980.PMID:16766856.
68. Umar, S., Umar, K., Sarwar, A.H., Khan, A., Ahmad, N., Ahmad, S., et al. 2014. Boswellia serrata extract attenuates inflammatory mediators and oxidative stress in collagen induced arthritis. Phytomedicine, 21(6): 847–856. doi:10.1016/j.phymed.2014.02.001.PMID:24667331.
69. Wallace, K.B. 2003. Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol. Toxicol. 93(3): 105–115. doi:10.1034/j.1600-0773.2003.930301.x.PMID: 12969434.
70. Winking, M., Sarikaya, S., Rahmanian, A., Jodicke, A., and Boker, D.K. 2000. Boswellic acids inhibit glioma growth: a new treatment option? J. Neurooncol. 46(2): 97–103. doi:10.1023/A:1006387010528.PMID:10894362.
71. Xiao, J., Sun, G.B., Sun, B., Wu, Y., He, L., Wang, X., et al. 2012. Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. Toxicology, 292(1): 53–62. doi:10.1016/j.tox.2011.11.018.PMID:22155320.
72. Yadav, V.R., Prasad, S., Sung, B., Gelovani, J.G., Guha, S., Krishnan, S., et al. 2012. Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers. Int. J. Cancer, 130(9): 2176–2184.
73. Zaitone, S.A., and Abo-Gresha, N.M. 2012. Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF. Eur. J. Pharmacol. 691(1): 134–142. doi:10.1016/j.ejphar.2012.06.022.PMID:22732653.
74. Zaitone, S.A., Barakat, B.M., Bilasy, S.E., Fawzy, M., Abdelaziz, E.Z., and Farag, N.F. 2015. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure. Naunyn Schmidberg Arch. Pharmacol. 1–14. In press. doi:10.1007/s00210-015-1102-9.PMID:25708949.
75. Zaki, A.A., Hashish, N.E., Amer, M.A., and Lahloub, M.F. 2014. Cardioprotective and antioxidant effects of oleogum resin “Olibanum” from Bos Boswellia carteri Birdw. (Bursearceae). Chin. J. Nat. Med. 12(5): 345–350.PMID:24856757.
76. Zhang, Y.W., Shi, J., Li, Y.J., and Wei, L. 2009. Cardiomyocyte death in doxorubicin-induced cardiotoxicity. Arch. Immunol. Ther. Exp. (Warsz.), 57(6): 435–445. doi:10.1007/s00005-009-0051-8.
77. Zordoky, B.N., Anwar-Mohamed, A., Aboutabl, M.E., and El-Kadi, A.O. 2010. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats. Toxicol. Appl. Pharmacol. 242(1): 38–46. doi:10.1016/j.taap.2009.09.012.PMID:19796650.xxxxxx.